Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 17, 2008 - Issue 7
Submit an article Journal homepage
172
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluations

Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a promising agent

Alvaro Morales Queen's University and General Hospital, Centre for Applied Urological Research, 62 Barrie Street, Kingston, Ontario, Canada K7L 3J7 +1 613 548 2424; +1 613 548 7836; [email protected]
Pages 1067-1073 | Published online: 12 Jun 2008

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Gary D Steinberg. (2011) Response to Lammers and Witjes article: new developments in intravesical therapy for non-muscle-invasive bladder cancer. Expert Review of Anticancer Therapy 11:9, pages 1331-1332.
Read now
Jeffrey J Tomaszewski & Marc C Smaldone. (2010) Emerging intravesical therapies for management of nonmuscle invasive bladder cancer. Open Access Journal of Urology 2, pages 67-84.
Read now
Marc C Smaldone, Daniel P Casella, Daniel R Welchons & Jeffrey R Gingrich. (2010) Investigational therapies for non-muscle invasive bladder cancer. Expert Opinion on Investigational Drugs 19:3, pages 371-383.
Read now

Articles from other publishers (13)

Solmaz Ohadian Moghadam & Mohammad Reza Nowroozi. (2019) Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy. Scandinavian Journal of Immunology 90:6.
Crossref
Jin-Feng Zhong, Wei-Gao Wu, Aseyinjan Tastan, Xiao-Qing Zhang, Bin Wang, Xiao-Peng Tang & Re-Jun Fang. (2018) Effects of an immune stimulant, inactivated Mycobacterium phlei, on the growth performance as well as meat quality of fattening pigs . Animal Science Journal 89:4, pages 703-712.
Crossref
C Mario Filion, Lucas Rodrigues, Chad Johannes & Aleksandar Masic. (2017) The in Vitro and in Vivo Anti-Cancer Potential of Mycobacterium Cell Wall Fraction (MCWF) Against Canine Transitional Cell Carcinoma of the Urinary Bladder. Acta Veterinaria 67:4, pages 477-494.
Crossref
Philip L. Ho, Stephen B. Williams & Ashish M. Kamat. (2015) Immune Therapies in Non-Muscle Invasive Bladder Cancer. Current Treatment Options in Oncology 16:2.
Crossref
Dong Zhang, Peng Sun, Peng Li, Aibing Xue, Xiaokai Zhang, Haiyang Zhang & Xunbo Jin. (2013) A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancer. Biomaterials 34:38, pages 10258-10266.
Crossref
Hélène LaRue, Cherifa Ayari, Alain Bergeron & Yves Fradet. (2013) Toll-like receptors in urothelial cells—targets for cancer immunotherapy. Nature Reviews Urology 10:9, pages 537-545.
Crossref
Erik L. Brincks, Michael C. Risk & Thomas S. Griffith. (2013) PMN and anti-tumor immunity—The case of bladder cancer immunotherapy. Seminars in Cancer Biology 23:3, pages 183-189.
Crossref
Cristian Speil & Robert Rzepka. (2011) Vaccines and Vaccine Adjuvants as Biological Response Modifiers. Infectious Disease Clinics of North America 25:4, pages 755-772.
Crossref
Timothy P. Kresowik & Thomas S. Griffith. 2010. Emerging Cancer Therapy. Emerging Cancer Therapy 49 70 .
Edmund Chiong & Kesavan Esuvaranathan. (2009) New therapies for non-muscle-invasive bladder cancer. World Journal of Urology 28:1, pages 71-78.
Crossref
J. Alfred Witjes, Kees Hendricksen, O. Gofrit, O. Risi & O. Nativ. (2009) Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo® working party. World Journal of Urology 27:3, pages 319-324.
Crossref
Timothy P KresowikThomas S Griffith. (2009) Bacillus Calmette–Guerin immunotherapy for urothelial carcinoma of the bladder. Immunotherapy 1:2, pages 281-288.
Crossref
R. Bartoletti & T. Cai. (2018) Endocavitary Prophylaxis of Superficial Urothelial Bladder Tumours: New Compounds. Urologia Journal 76:1, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.